INSP — Inspire Medical Systems Income Statement
0.000.00%
Last trade - 00:00- $1.44bn
- $1.14bn
- $911.98m
Annual income statement for Inspire Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 233 | 408 | 625 | 803 | 912 |
| Cost of Revenue | |||||
| Gross Profit | 200 | 342 | 528 | 680 | 779 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 273 | 455 | 665 | 767 | 865 |
| Operating Profit | -39.9 | -47.6 | -40.3 | 36.1 | 47 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -42 | -44.3 | -19.9 | 58.5 | 65.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -42 | -44.9 | -21.2 | 53.5 | 145 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -42 | -44.9 | -21.2 | 53.5 | 145 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -42 | -44.9 | -21.2 | 53.5 | 145 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.54 | -1.6 | -0.722 | 1.75 | 4.97 |